These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12793872)

  • 1. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
    Claessens YE; Chiche JD; Mira JP; Cariou A
    Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors].
    Pedrol E; Ribell M; Deig E; Villà Mdel C; Miró O; Garrabou G; Soler A
    Med Clin (Barc); 2005 Jul; 125(6):201-4. PubMed ID: 16022831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.
    Brinkman K
    Clin Infect Dis; 2000 Jul; 31(1):167-9. PubMed ID: 10913416
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lactic acidosis in HIV-patients--diagnosis and treatment].
    Walker UA
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():65-7. PubMed ID: 15373054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.
    Claessens YE; Cariou A; Chiche JD; Dauriat G; Dhainaut JF
    AIDS; 2000 Mar; 14(4):472-3. PubMed ID: 10770558
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases.
    ter Hofstede HJ; de Marie S; Foudraine NA; Danner SA; Brinkman K
    Int J STD AIDS; 2000 Sep; 11(9):611-6. PubMed ID: 10997508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acidosis related to nucleoside therapy in HIV-infected patients.
    Falcó V; Crespo M; Ribera E
    Expert Opin Pharmacother; 2003 Aug; 4(8):1321-9. PubMed ID: 12877640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlactataemia syndromes associated with HIV therapy.
    Ogedegbe AE; Thomas DL; Diehl AM
    Lancet Infect Dis; 2003 Jun; 3(6):329-37. PubMed ID: 12781504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.
    Posteraro AF; Mauriello M; Winter SM
    Conn Med; 2001 Jul; 65(7):387-90. PubMed ID: 11508132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine.
    Claessens YE; Cariou A; Monchi M; Soufir L; Azoulay E; Rouges P; Goldgran-Toledano D; Branche F; Dhainaut JF
    Crit Care Med; 2003 Apr; 31(4):1042-7. PubMed ID: 12682470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
    Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
    Dieterich DT
    AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors.
    Pao D; Watson C; Peters B; Lucas SB; Miller RF
    Sex Transm Infect; 2001 Oct; 77(5):381-4. PubMed ID: 11588287
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.
    Goldfarb-Rumyantzev AS; Jeyakumar A; Gumpeni R; Rubin D
    AIDS Patient Care STDS; 2000 Jul; 14(7):339-42. PubMed ID: 10935049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.